|
Pazopanib Impurity 1
|
2-氯-4-羥基嘧啶
|
55873-09-1
|
|
Landiolol Impurity 25
|
蘭地洛爾雜質(zhì)30
|
2414593-71-6
|
|
Ambroxol EP Impurity A
|
2-氨基-3,5-二溴芐醇
|
50739-76-9
|
|
Trazodone EP Impurity C
|
4-Chloro Trazodone
|
157072-19-0
|
|
Biotin EP Impurity D
|
生物素雜質(zhì)D
|
415725-35-8
|
|
Ranolazine USP Related Compound B
|
雷諾嗪雜質(zhì)
|
755711-09-2
|
|
6-Hydroxy Chlorzoxazone
|
6-.羥基氯唑沙宗
|
1750-45-4
|
|
Cycloserine Impurity 2
|
環(huán)絲氨酸雜質(zhì)5
|
15996-22-2
|
|
Duloxetine EP Impurity B
|
(S)-3-(甲氨基)-1-(2-噻吩基)-1-丙醇
|
116539-55-0
|
|
Biotin EP Impurity F
|
生物素EP雜質(zhì)F
|
101469-35-6
|
|
Landiolol Impurity 2 HCl
|
鹽酸蘭地洛爾異構體Ⅰ
|
1253907-83-3
|
|
Landiolol Impurity 1
|
蘭地洛爾雜質(zhì)7
|
144256-26-8
|
|
Cyanocobalamin EP Impurity C
|
34-甲基氰鈷胺
|
38218-51-8
|
|
Duloxetine EP Impurity E
|
度洛西汀EP雜質(zhì)E
|
1033803-59-6
|
|
Flucloxacillin sodium EP Impurity C
|
6-氨基青霉烷酸
|
551-16-6
|
|
Landiolol Impurity 11
|
144256-12-2
|
144256-12-2
|
|
Trazodone Impurity 1
|
1-(3-氯苯基)-4-(3-氯丙基)哌嗪
|
39577-43-0
|
|
Avanafil Impurity 30
|
阿伐那非雜質(zhì)26
|
2250242-42-1
|
|
Mycophenolate Mofetil EP Impurity H
|
霉酚酸酯EP雜質(zhì)H(霉酚酸酯-USP相關化合物B)
|
26675-76-3
|
|
Trazodone EP Impurity M
|
Isotrazodone
|
157072-18-9
|
|
Duloxetine EP Impurity A
|
R-(-)-度洛西汀
|
116539-60-7
|
|
Mycophenolate Mofetil EP Impurity A
|
霉酚酸酯雜質(zhì)A
|
1322681-36-6
|
|
Posaconazole Impurity 23
|
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
|
2243785-97-7
|
|
Trazodone EP Impurity A HCl
|
曲唑酮USP雜質(zhì)A
|
55290-66-9
|
|
Landiolol Impurity 5
|
蘭地洛爾雜質(zhì)32
|
93605-74-4
|
|
Posaconazole Impurity 27
|
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
|
2243785-98-8
|
|
Biotin EP Impurity C
|
生物素雜質(zhì)
|
22342-46-7
|
|
Eltrombopag Impurity 21
|
Diazene, 1,2-bis(3,4-dimethylphenyl)-
|
29418-36-8
|
|
Nicardipine Impurity 12
|
|
132100-30-2
|
|
Salbutamol EP Impurity B
|
沙丁胺醇EP雜質(zhì)B
|
96948-64-0
|
|
Cycloserine Impurity 4
|
乙酰半胱氨酸雜質(zhì)
|
16337-02-3
|
|
Perindopril L-Arginine
|
培哚普利精氨酸
|
612548-45-5
|
|
Posaconazole Impurity 34
|
泊沙康唑雜質(zhì)39
|
161532-65-6
|
|
Cyanocobalamin EP Impurity E
|
氰鈷銨素雜質(zhì)
|
41325-63-7
|
|
Trazodone EP Impurity H 2HCl
|
Trazodone Hydrochloride BP Impurity H DiHCl
|
2408971-27-5
|
|
Tranexamic Acid EP Impurity F
|
氨甲環(huán)酸雜質(zhì)F
|
1599413-49-6
|
|
Landiolol Impurity 1 HCl
|
鹽酸蘭地洛爾異構體Ⅱ
|
1253907-85-5
|
|
Perindopril EP Impurity P
|
1-[2-[[1-(ethoxycarbonyl)butyl]amino]propionyl]octahydro-1H-indole-2-carboxylic acid
|
82978-68-5
|
|
Trazodone EP Impurity G HCl
|
雜質(zhì)曲唑酮鹽酸G
|
2470441-00-8
|
|
Landiolol Impurity 2
|
蘭地洛爾雜質(zhì)8
|
144256-25-7
|
|
Landiolol Impurity 4
|
蘭地洛爾雜質(zhì)40
|
4432-25-1
|
|
Tranexamic Acid EP Impurity B
|
4-(氨基甲基)環(huán)己酸
|
1197-17-7
|
|
Rocuronium Bromide Impurity 2
|
5alpha-雄甾-2-烯-17-酮
|
963-75-7
|
|
Ranolazine USP Related Compound A
|
愈創(chuàng)木酚縮水甘油醚
|
2210-74-4
|
|
Landiolol Impurity 6
|
蘭地洛爾雜質(zhì)28
|
69630-20-2
|
|
Mycophenolate Mofetil EP Impurity G
|
霉酚酸酯雜質(zhì)G
|
224052-51-1
|
|
Neostigmine Impurity 1
|
新斯的明二聚體
|
63468-95-1
|
|
Posaconazole Impurity 31
|
泊沙康唑雜質(zhì)23
|
687132-01-0
|
|
Avanafil Impurity 32
|
4-[[(3-氯-4-甲氧基苯基)甲基]氨基]-2-[(2R)-2-(羥甲基)-1-吡咯烷基]-N-(2-嘧啶基甲基)-5-嘧啶甲酰胺
|
1638497-26-3
|
|
Flucloxacillin sodium EP Impurity B
|
FLUCLOXACILLIN
|
1276016-89-7
|
|
Posaconazole Impurity 24
|
4-[4-[4-[4-[[(3R,5S)-5-(2,4-二氟苯基)四氫-5-(1H-1,2,4-三唑-1-基甲基)-3-呋喃基]甲氧基]苯基]-1-哌嗪基]苯基]-2-[(1S,2S)-1-乙基-2-羥丙基]-2,4-二氫-3H-1,2,4-三唑-3-酮
|
2243785-96-6
|
|
Salbutamol EP Impurity J
|
沙丁胺醇相關物質(zhì)B
|
156547-62-5
|
|
Ranolazine USP Related Compound C
|
N-(2,6-二甲基苯基)-1-哌嗪乙酰胺
|
5294-61-1
|
|
Biotin Impurity 1
|
吡哆素雜質(zhì)33
|
4375-00-2
|
|
Perindopril Impurity 9
|
培哚普利雜質(zhì)19
|
145513-38-8
|
|
Landiolol Impurity 3
|
蘭地洛爾雜質(zhì)2
|
133242-29-2
|
|
Benidipine Impurity 7
|
1-芐基-3-羥基氯化吡啶
|
3323-73-7
|
|
Landiolol Impurity 35
|
N-(2-氨基乙基)-4-嗎啉甲酰胺草酸鹽
|
154467-16-0
|
|
Trazodone Impurity 2 HCl
|
鹽酸曲唑酮雜質(zhì)18
|
1263278-79-0
|
|
Posaconazole Impurity 26
|
泊沙康唑雜質(zhì)
|
1229428-90-3
|
|
Cinnarizine EP Impurity D
|
桂利嗪EP雜質(zhì)D
|
1415587-79-9
|
|
Nicardipine Impurity 10
|
尼卡地平雜質(zhì)26
|
167963-66-8
|
|
Perindopril Impurity 10
|
培哚普利EP雜質(zhì)A
|
145513-32-2
|
|
Cinnarizine EP Impurity C
|
桂利嗪雜質(zhì)C
|
95062-18-3
|
|
Benidipine Impurity 6
|
3-芐氧基哌啶
|
1185304-22-6
|
|
Posaconazole Impurity 20
|
泊沙康唑雜質(zhì)
|
170985-61-2
|
|
Rocuronium Bromide Impurity 3
|
5-雄甾-3-烯-17-酮
|
14935-81-0
|
|
Mycophenolate Mofetil EP Impurity C
|
霉酚酸酯EP雜質(zhì)C
|
2286278-51-9
|
|
Landiolol Impurity 3 HCl
|
鹽酸蘭地洛爾異構體Ⅲ
|
1253907-81-1
|
|
Tranexamic Acid EP Impurity C
|
氨甲環(huán)酸雜質(zhì)C
|
330838-52-3
|
|
Salbutamol EP Impurity A
|
沙丁胺醇雜質(zhì)A
|
870076-72-5
|
|
Mycophenolate Mofetil Impurity 1
|
霉酚羥基內(nèi)酯
|
26644-06-4
|
|
Avanafil Impurity 38
|
阿伐那非雜質(zhì)
|
330785-05-2
|
|
Landiolol Impurity 18
|
蘭地洛爾雜質(zhì)
|
190601-22-0
|
|
Cycloserine Impurity 5
|
環(huán)絲氨酸雜質(zhì)8
|
15996-16-4
|
|
Mycophenolate Mofetil EP Impurity E
|
霉酚酸酯雜質(zhì)E
|
31858-66-9
|
|
Duloxetine EP Impurity G
|
1-氟萘
|
321-38-0
|
|
Cinnarizine EP Impurity B
|
桂利嗪雜質(zhì)B
|
750512-44-8
|
|
Biotin EP Impurity B
|
生物素雜質(zhì)B
|
57671-79-1
|
|
Mycophenolate Mofetil EP Impurity F
|
霉酚酸
|
24280-93-1
|
|
Cyanocobalamin EP Impurity D
|
氰鈷銨素雜質(zhì)
|
121483-62-3
|
|
Duloxetine EP Impurity F
|
度洛西汀EP雜質(zhì)F
|
959392-22-4
|
|
Posaconazole Impurity 25
|
泊沙康唑雜質(zhì)20
|
1229428-91-4
|
|
Landiolol Impurity 7
|
蘭地洛爾雜質(zhì)2
|
2180628-04-8
|
|
Biotin EP Impurity G Bromide
|
生物素EP雜質(zhì)G溴化物
|
33719-11-8
|
|
Nicardipine Impurity 11
|
尼卡地平雜質(zhì)24
|
40641-47-2
|
|
Carbazochrome impurity 1
|
卡絡磺鈉雜質(zhì)7
|
2666934-59-2
|
|
Trazodone EP Impurity G 2HCl
|
鹽酸曲唑酮EP雜質(zhì)G
|
2512213-25-9
|
|
Cycloserine Impurity 3
|
3,6-雙(2-羥乙基)-2,5-二酮哌嗪
|
50975-79-6
|
|
Nicardipine EP Impurity A DiHCl
|
鹽酸尼卡地平EP雜質(zhì)A二鹽酸鹽
|
2724726-76-3
|
|
Neostigmine EP Impurity B
|
3-羥基-N,N-二甲基苯胺
|
99-07-0
|
|
Duloxetine EP Impurity C
|
(RS)-4-[3-甲氨基-1-(2-噻吩基)丙基]-1-萘酚
|
949095-98-1
|
|
Tazobactam USP Related Compound A
|
[S-(R*,R*)]-α-AMino-β-Methyl-β-sulfino-1H-1,2,3-triazole-1-butanoic Acid
|
120701-87-3
|
|
Posaconazole Impurity 21
|
泊沙康唑雜質(zhì)
|
171228-50-5
|
|
Benidipine Impurity 4
|
2-BUTENOIC ACID, 3-AMINO-, 1-(PHENYLMETHYL)-3-PIPERIDINYL ESTER
|
91599-78-9
|
|
Flucloxacillin sodium EP Impurity E
|
氟氯西林EP雜質(zhì)E
|
1483237-81-5
|
|
Posaconazole Impurity 22
|
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
|
2243785-99-9
|
|
Posaconazole Impurity 28
|
泊沙康唑雜質(zhì)28
|
186805-99-2
|
|
Trazodone EP Impurity D
|
Trazodone impurity 3/Trazodone Bromo Analog/2-{3-[4-(3-Bromophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one
|
1263358-13-9
|
|
Neostigmine EP Impurity C
|
N,N-二甲基氨基甲酸-3-(二甲基氨基)苯酯
|
16088-19-0
|